The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $11.84

Today's change-0.30 -2.43%
Updated June 25 1:01 PM EDT. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $11.84

Today's change-0.30 -2.43%
Updated June 25 1:01 PM EDT. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc down (U.S.)$0.30

Allscripts Healthcare Solutions Inc is sharply lower today, dropping (U.S.)$0.30 or 2.43% to (U.S.)$11.84. Over the last five days, shares have lost 5.17% and are down 18.66% for the last year to date. This security has underperformed the S&P 500 by 18.69% during the last year.

Key company metrics

  • Open(U.S.) $12.11
  • Previous close(U.S.) $12.13
  • High(U.S.) $12.16
  • Low(U.S.) $11.81
  • Bid / Ask(U.S.) $11.83 / (U.S.) $11.84
  • YTD % change-18.66%
  • Volume596,708
  • Average volume (10-day)2,085,783
  • Average volume (1-month)1,643,971
  • Average volume (3-month)2,068,127
  • 52-week range(U.S.) $10.78 to (U.S.) $16.13
  • Beta1.24
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward15.79×
  • Forward PEG0.87×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.45
Updated June 25 1:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-11.51%

Although this company's net profit margin is negative, it is above the industry average and implies that Allscripts Healthcare Solutions Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX1.31%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2018Q4/2017Q3/2017Q2/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201803/31/2018Dec 31, 201712/31/2017Sep 30, 201709/30/2017Jun 30, 201706/30/2017
Revenue514517449426
Total other revenue--------
Total revenue514517449426
Gross profit221214202187
Total cost of revenue293303248239
Total operating expense525533445550
Selling / general / administrative143146117112
Research & development70735146
Depreciation / amortization121088
Interest expense (income), net operating--------
Unusual expense (income)6021145
Other operating expenses, total--------
Operating income-11-165-123
Interest income (expense), net non-operating-25-25-22-20
Gain (loss) on sale of assets--------
Other--------
Income before tax-36-40-18-144
Income after tax-33-26-17-143
Income tax, total-3-130-1
Net income-2817-18-143
Total adjustments to net income-12-11-11-11
Net income before extra. items-32-24-18-143
Minority interest1200
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-44-35-29-154
Inc. avail. to common incl. extra. items-406-29-154
Diluted net income-406-29-154
Dilution adjustment--------
Diluted weighted average shares180181181181
Diluted EPS excluding extraordinary itemsvalue per share-0.25-0.19-0.16-0.85
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.22-0.19-0.08-0.33